News

May 25, 2010 – The highly anticipated first results of the RESOLUTE All Comers study were presented today during the late-breaking clinical trial session of the 2010 EuroPCR meeting in Paris. In the 2,292-patient randomized trial, Medtronic’s Resolute zotarolimus-eluting stent was found to be as safe and effective as Abbott’s Xience V everolimus-eluting stent.

Home May 25, 2010
Home
News

May 25, 2010 – The first patient has been implanted with a bare metal coronary stent mounted on a drug-eluting balloon in the European Pioneer trial, which began this week.

Home May 25, 2010
Home
News

May 25, 2010 – A self-expanding, drug-eluting stent (DES) that just gained CE mark clearance in Europe is designed to ensure optimal apposition in the initial hours and days after an acute myocardial infarction (AMI) procedure.

Home May 25, 2010
Home
News

May 24, 2010 - Utilizing the iso-osmolar agent Visipaque (iodixanol) could save hospitals $54,617 per 100 patients when compared to the low osmolar nonionic agent iopamidol. This was according to results from a study presented at the American Heart Association’s Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Scientific Sessions in Washington, D.C., held May 19-21.

Home May 24, 2010
Home
News

May 24, 2010 – New intravascular imaging innovations, such as registered angiography and intravascular ultrasound (IVUS), forward-looking IVUS and a combined IVUS/balloon catheter will be highlighted May 25-28 at EuroPCR in Paris. Volcano Corp. will spotlight new product launches and its works in progress at the conference. The new product introductions include:

Home May 24, 2010
Home
News

May 24, 2010 – The U.S. Justice Department settled a pay-to-play scheme at The Christ Hospital last week for $108 million. The hospital only allowed access to its Heart Station outpatient cardiology testing and noninvasive heart procedure unit to cardiologists who referred cardiac business to the hospital.

Home May 24, 2010
Home
Technology

May 24, 2010 – New collaborations will enable the use of Boston Scientific’s iLab Ultrasound Imaging System with the Philips’ Allura Xper and the Siemens’ Axiom Artis and Artis zee interventional X-ray systems. The iLab provides both intravascular ultrasound (IVUS) and intracardiac ultrasound (ICE).

Home May 24, 2010
Home
News

May 21, 2010 – A second company is hoping to gain U.S. Food and Drug Administration (FDA) clearance for an optical coherence tomography (OCT) intravascular imaging system. Volcano Corp. said its second generation OCT system is pending FDA investigational device exemption (IDE) approval so it can start its VOILA clinical trial in the United States and South America.

Home May 21, 2010
Home
News

May 21, 2010 – The first successful transcatheter mitral valve implantation (TMVI) for a new mitral valve technology will be highlighted at the EuroPCR 2010 scientific meeting in Paris. A proprietary transcatheter delivery system was used to successfully deliver the valve in the porcine model.

Home May 21, 2010
Home
News

May 21, 2010 – Results of an in vivo study of 48 porcine arteries implanted with a biodegradable stent showed biodegradation is measurable and begins at the first day of implant. However, high radial strength is maintained during biodegradation.

Home May 21, 2010
Home
News

May 21, 2010 – A new stent delivery system is designed to be reliable, easy to use and precise when delivering the self-expanding Supera peripheral vascular stent. The new delivery system was launched this week in Europe. The Supera Veritas system was developed to deliver the Supera for the treatment of biliary and peripheral artery disease (PAD).

Home May 21, 2010
Home
News

May 20, 2010 - The International Symposium on Multidetector-Row CT held May 19 in San Francisco, Calif., hosted the “Workstation Face-Off,” which challenged providers of advanced 3-D image processing technologies to process and interpret three complex computed tomography (CT) imaging studies.

Home May 20, 2010
Home
News

May 20, 2010 - Seven advanced visualization systems companies competed at the annual “Workstation Challenge” held at the 2010 International Symposium on Multidetector Row CT (ISCT) held in San Francisco, Calif.

Home May 20, 2010
Home
Technology

May 20, 2010 – A fractional flow reserve (FFR) guide wire gained U.S. Food and Drug Administration (FDA) clearance and European CE mark to speed treatment of multivessel disease. These blockages usually have more tortuous tissue to navigate through and it takes longer to guide several devices over-the-wire to deliver treatment.

Home May 20, 2010
Home
News

May 20, 2010 – An aortic embolic protection device, which acts as a protective shield to reduce the incidence of embolization to the brain, was granted CE mark approval this week in Europe. The Embrella Embolic Deflector will serve as an adjunctive device to be used in procedures such as transcatheter aortic valve implantation (TAVI) procedures.

Home May 20, 2010
Home
Subscribe Now